AxoGen - 35 Year Stock Price History | AXGN
Historical daily share price chart and data for AxoGen since 1990 adjusted for splits and dividends. The latest closing stock price for AxoGen as of January 17, 2025 is 18.09.
- The all-time high AxoGen stock closing price was 55.90 on July 23, 2018.
- The AxoGen 52-week high stock price is 18.96, which is 4.8% above the current share price.
- The AxoGen 52-week low stock price is 5.55, which is 69.3% below the current share price.
- The average AxoGen stock price for the last 52 weeks is 10.71.
| AxoGen Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 16.9845 | 16.4000 | 18.7300 | 14.5600 | 18.0900 | 9.77% |
| 2024 | 10.2816 | 6.9100 | 17.1900 | 5.6700 | 16.4800 | 141.29% |
| 2023 | 7.7263 | 9.8800 | 10.9500 | 3.6100 | 6.8300 | -31.56% |
| 2022 | 9.5826 | 9.9800 | 13.0900 | 6.9900 | 9.9800 | 6.51% |
| 2021 | 17.4408 | 17.5100 | 23.5000 | 8.8000 | 9.3700 | -47.65% |
| 2020 | 12.0044 | 17.3400 | 17.9600 | 7.3450 | 17.9000 | 0.06% |
| 2019 | 17.7071 | 20.6300 | 25.4700 | 11.1800 | 17.8900 | -12.43% |
| 2018 | 37.4970 | 27.9500 | 55.9000 | 17.0900 | 20.4300 | -27.81% |
| 2017 | 16.0429 | 8.9000 | 28.6000 | 8.8000 | 28.3000 | 214.44% |
| 2016 | 6.8839 | 5.0500 | 9.3600 | 4.6100 | 9.0000 | 80.00% |
| 2015 | 3.9119 | 3.6000 | 5.6400 | 3.0200 | 5.0000 | 39.28% |
| 2014 | 3.0089 | 4.8100 | 4.8600 | 2.1500 | 3.5900 | -20.04% |
| 2013 | 4.0078 | 2.7500 | 5.0800 | 2.7500 | 4.4900 | 66.30% |
| 2012 | 2.9554 | 2.6000 | 3.9900 | 2.2500 | 2.7000 | 0.00% |
| 2011 | 2.7243 | 4.0000 | 4.0000 | 2.0000 | 2.7000 | -22.64% |
| 2010 | 3.5169 | 3.3955 | 5.1627 | 2.7000 | 3.4900 | 6.11% |
| 2009 | 3.3106 | 2.2500 | 4.6227 | 1.6364 | 3.2891 | 46.18% |
| 2008 | 2.3995 | 1.0636 | 4.0909 | 1.0636 | 2.2500 | 111.55% |
| 2007 | 1.8761 | 0.6955 | 6.1364 | 0.4500 | 1.0636 | 100.00% |
| 2006 | 0.3745 | 0.4173 | 0.6545 | 0.1964 | 0.5318 | 27.44% |
| 2005 | 1.1510 | 1.1961 | 2.3523 | 0.4173 | 0.4173 | -65.11% |
| 2004 | 0.9060 | 0.5582 | 1.4353 | 0.4784 | 1.1961 | 85.18% |
| 2003 | 0.3866 | 0.3907 | 0.7894 | 0.2073 | 0.6459 | 58.81% |
| 2002 | 0.7809 | 1.2997 | 2.3012 | 0.1834 | 0.4067 | -60.77% |
| 2001 | 1.4808 | 1.4991 | 2.2725 | 0.8054 | 1.0366 | -30.67% |
| 2000 | 2.0759 | 1.1961 | 3.9622 | 0.7974 | 1.4951 | 15.39% |
| 1999 | 2.1898 | 2.0437 | 3.2398 | 1.0470 | 1.2957 | -38.10% |
| 1998 | 3.0817 | 4.3856 | 4.5849 | 1.8938 | 2.0931 | -48.78% |
| 1997 | 5.0524 | 5.3823 | 7.1764 | 3.5882 | 4.0866 | -29.31% |
| 1996 | 8.1252 | 8.7712 | 12.1601 | 4.7843 | 5.7810 | -34.09% |
| 1995 | 8.3717 | 6.0800 | 11.3627 | 5.7810 | 8.7712 | 51.72% |
| 1994 | 7.1290 | 7.5751 | 8.5718 | 5.3823 | 5.7810 | -30.95% |
| 1993 | 8.5982 | 9.1699 | 9.9673 | 7.1764 | 8.3725 | -6.67% |
| 1992 | 8.2522 | 8.5718 | 11.1633 | 5.7810 | 8.9705 | 1.08% |
| 1991 | 6.8816 | 2.7908 | 12.1601 | 2.3921 | 8.8748 | 218.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.796B | $0.159B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |